<DOC>
	<DOCNO>NCT00514735</DOCNO>
	<brief_summary>The purpose trial evaluate safety efficacy Medtronic Cardiac Ablation System compare medical therapy persistent long-standing persistent atrial fibrillation population .</brief_summary>
	<brief_title>Tailored Treatment Permanent Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>INCLUSION CRITERIA : History symptomatic , continuous atrial fibrillation define : Continuous atrial fibrillation last great 1 year less 4 year nonselfterminating atrial fibrillation , last great 7 day 1 year , least one fail direct current cardioversion . A failed cardioversion define unsuccessful cardioversion one normal sinus rhythm establish maintain beyond 7 day . Atrial fibrillation symptom include follow : palpitation , fatigue , exertional dyspnea , exercise intolerance Age 18 70 year Failure least one Class I III rhythm control drug Willingness , ability commitment participate baseline followup evaluation full length study . EXCLUSION CRITERIA : Structural heart disease clinical significance include : Previous cardiac surgery ( exclude coronary artery bypass graft mitral valve repair ) Symptoms congestive heart failure include , limited , New York Heart Association ( NYHA ) Class III IV congestive heart failure and/or document ejection fraction &lt; 40 % measure acceptable cardiac testing Left atrial diameter &gt; 55 mm Moderate severe mitral aortic valvular heart disease Stable/unstable angina ongoing myocardial ischemia Myocardial infarction ( MI ) within 3 month enrollment Congenital heart disease ( include atrial septal defect patent foramen ovale without right left shunt ) underlie abnormality increase risk ablative procedure Prior atrial septal defect patent foramen ovale closure device use percutaneous approach Hypertrophic cardiomyopathy ( left ventricular septal wall thickness &gt; 1.5 cm ) Pulmonary hypertension ( mean systolic pulmonary artery pressure &gt; 50 mm Hg Doppler echo ) Any prior ablation atrial fibrillation Enrollment ongoing arrhythmia study Any ventricular tachyarrhythmia currently treat arrhythmia management may interfere study Active infection sepsis Any history cerebral vascular disease include stroke transient ischemic attack Pregnancy lactation Left atrial thrombus time ablation Untreatable allergy contrast medium Any diagnosis atrial fibrillation secondary electrolyte imbalance , thyroid disease , reversible noncardiovascular cause History blood clotting ( bleed thrombotic ) abnormalities Known sensitivity heparin warfarin Severe chronic obstructive pulmonary disease ( define force expiratory volume 1 ( FEV1 ) &lt; 1 ) Severe comorbidity poor general physical/mental health , opinion investigator , allow subject good study candidate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>atrial fibrillation</keyword>
</DOC>